GSE135223

Human macrophage responses to viral-like particles from non-IBD or IBD colonic resections

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

10 case / 8 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Summary

Peripheral blood-derived macrophages were stimulated with viral-like particles isolated from colonic resections from patients with Crohn's disease (CD), ulcerative colitis (UC), or non-IBD controls diagnoses. RNAseq was performed to unbiasedly assess the transcriptional responses to these stimuli and revealed highly divergent macrophage transcriptional programs in response to non-IBD compared to IBD VLP.

Overall design

Peripheral blood mononuclear cells from the blood of three healthy human donors were pooled and differentiated into macrophages with M-CSF over the course of seven days. Mature macrophages were treated with viral-like particle (VLP) isolates from colon resections of patients with Crohn's disease (5 individual patient samples), ulcerative colitis (5 individual patient samples), non-IBD diagnoses (5 individual patient samples), or mock treated (3 replicates of mock treatment). RNA was isolated and RNA-seq was carried out for transcriptional analysis.

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
18 GSM samples
Primary source
recount3

Planned trusted source for processed count availability.

No match found
Expression Atlas

Planned source for curated expression experiment links.

No match found
PubMed

Primary GEO citations and related PubMed articles that mention this dataset.

1 linked publication 1 DOI

Primary publication

  1. Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation. Science immunology, 2022
Available

Metadata Quality Components

Analysis Readiness

Ready after review
97% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

7/10 pts

Warnings are present, but none are critical blockers.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

No readiness blockers detected.

Next Steps

  • Verify the proposed sample assignments and case-versus-control comparison against the GEO metadata before using them in DESeq2 or another differential-expression tool.
  • Confirm processed count files and sample identifiers match the exported metadata.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Standard analyst review

Proceed only after the analyst confirms grouping, exclusions, and source files.

By Siftome standards, no expert review was triggered.

Why This Is Ranked Here

Tumor vs normal
Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Disease context Crohn's disease, inflammatory bowel disease, ulcerative colitis Disease context came from Normalization rules.
  • Likely case group Crohn's disease 10 samples
  • Likely control group Mixed controls 8 samples

Intent Interpretation

  • Downgrade or exclusion reason Comparison: Disease/model vs control. Specimen: Unclear specimen/source. Comparison suitability: 0%. Derived from current-intent ranking reasons.

Ranking Facts

Supporting evidence

  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Crohn's disease, Inflammatory bowel disease, Ulcerative colitis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 35394816.
  • Publication context: Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation.. Science immunology, 2022. PMID 35394816. DOI 10.1126/sciimmunol.abn6660.

Cautions

  • Comparison: Disease/model vs control. Specimen: Unclear specimen/source. Comparison suitability: 0%.
  • Downgraded for tissue search because study design or specimen source is unclear.
  • Disease/control design without a tumor/normal comparison is outside tumor/normal triage.
  • Unclear specimen/source downgraded for patient tissue tumor-vs-normal search intent.
  • Missing or unclear metadata. Unclear specimen/source downgraded for patient tissue tumor-vs-normal search intent.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Missing or unclear metadata. Comparison - Disease/model vs control. Specimen - Unclear specimen/source. Comparison suitability: 0%.
  • Missing or unclear metadata. Downgraded for tissue search because study design or specimen source is unclear.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

Normalized Fields

32 fields

Sample Group Preview

18 rows shown
Show Hide
Study totals: Case 10 | Control 8 | Unassigned 0 | Excluded 0 | Ambiguous 0 18 rows shown
Group Role Accession Title Source / characteristics Reason
Crohn's disease Case GSM3995429 Crohn's Disease rep 1 Macrophage Disease: Crohn's Disease Case marker detected.
Crohn's disease Case GSM3995430 Crohn's Disease rep 2 Macrophage Disease: Crohn's Disease Case marker detected.
Crohn's disease Case GSM3995431 Crohn's Disease rep 3 Macrophage Disease: Crohn's Disease Case marker detected.
Crohn's disease Case GSM3995432 Crohn's Disease rep 4 Macrophage Disease: Crohn's Disease Case marker detected.
Crohn's disease Case GSM3995433 Crohn's Disease rep 5 Macrophage Disease: Crohn's Disease Case marker detected.
Ulcerative colitis Case GSM3995442 Ulcerative Colitis rep 1 Macrophage Disease: Ulcerative Colitis Case marker detected.
Ulcerative colitis Case GSM3995443 Ulcerative Colitis rep 2 Macrophage Disease: Ulcerative Colitis Case marker detected.
Ulcerative colitis Case GSM3995444 Ulcerative Colitis rep 3 Macrophage Disease: Ulcerative Colitis Case marker detected.
Ulcerative colitis Case GSM3995445 Ulcerative Colitis rep 4 Macrophage Disease: Ulcerative Colitis Case marker detected.
Ulcerative colitis Case GSM3995446 Ulcerative Colitis rep 5 Macrophage Disease: Ulcerative Colitis Case marker detected.
Healthy control Control GSM3995434 Healthy Control rep 1 Macrophage Disease: Healthy Control Sample-local control marker detected.
Healthy control Control GSM3995435 Healthy Control rep 2 Macrophage Disease: Healthy Control Sample-local control marker detected.
Healthy control Control GSM3995436 Healthy Control rep 3 Macrophage Disease: Healthy Control Sample-local control marker detected.
Healthy control Control GSM3995437 Healthy Control rep 4 Macrophage Disease: Healthy Control Sample-local control marker detected.
Healthy control Control GSM3995438 Healthy Control rep 5 Macrophage Disease: Healthy Control Sample-local control marker detected.
Control Control GSM3995439 Mock rep 1 Macrophage Disease: Mock Sample-local control marker detected.
Control Control GSM3995440 Mock rep 2 Macrophage Disease: Mock Sample-local control marker detected.
Control Control GSM3995441 Mock rep 3 Macrophage Disease: Mock Sample-local control marker detected.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.